Number of individuals included in the cross-sectional study, the cohort study of diabetes risk and the cohort study of comorbidity
| Women | Men | |||
| Total n | With diabetes n (%) | Total n | With diabetes n (%) | |
| Cross-sectional study* | ||||
| LBP | ||||
| Absent | 16 768 | 296 (1.8) | 16 482 | 397 (2.4) |
| Present | 6810 | 148 (2.2) | 5097 | 133 (2.6) |
| Cohort study of diabetes risk† | ||||
| LBP at baseline | ||||
| Absent | 11 883 | 364 (3.1) | 10 511 | 453 (4.3) |
| Present | 4669 | 222 (4.8) | 3317 | 163 (4.9) |
| Age at baseline (years) | ||||
| 30–39 | 4315 | 55 (1.3) | 3321 | 57 (1.7) |
| 40–49 | 5314 | 152 (2.9) | 4584 | 172 (3.8) |
| 50–59 | 4281 | 205 (4.8) | 3698 | 240 (6.5) |
| 60–69 | 2642 | 174 (6.6) | 2225 | 147 (6.6) |
| BMI at baseline (kg/m2) | ||||
| ≤24.9 | 7555 | 66 (0.9) | 4470 | 50 (1.1) |
| 25–29.9 | 6367 | 215 (3.4) | 7478 | 297 (4.0) |
| 30–34.9 | 1994 | 198 (9.9) | 1634 | 197 (12.1) |
| ≥35 | 594 | 105 (17.7) | 211 | 67 (31.8) |
| Cohort study of comorbidity‡ | ||||
| LBP at follow-up | ||||
| Absent | 8049 | 252 (3.1) | 7317 | 316 (4.3) |
| Present | 2082 | 60 (2.9) | 1244 | 59 (4.7) |
*Includes individuals with information at baseline, with possible diagnosis of diabetes at the same stage.
†Includes individuals without diabetes at baseline, under risk of diabetes at the end of follow-up.
‡Includes individuals without diabetes or LBP at baseline, under risk of diabetes and LBP at the end of follow-up.
BMI, body mass index; LBP, low back pain.